Seeing Is Believing
Currently out of the existing stock ratings of Juan Avendano, 2 are a HOLD (40%), 1 are a SELL (20%), 2 are a BUY (40%).
Analyst Juan Avendano, carries an average stock price target met ratio of 100% that have a potential upside of 9.21% achieved within 45 days.
Juan Avendano’s has documented 10 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on WST, West Pharmaceutical Services at 21-Jul-2020.
Analyst best performing recommendations are on CRL (CHARLES RIVER LABORATORIES).
The best stock recommendation documented was for CRL (CHARLES RIVER LABORATORIES) at 7/1/2020. The price target of $192 was fulfilled within 14 days with a profit of $16.44 (9.36%) receiving and performance score of 6.69.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 24-Jun-2025
$325
$65.21 (25.10%)
$275
2 months 24 days ago
(27-Oct-2025)
2/3 (66.67%)
$37.78 (13.15%)
25
Buy
Since 09-Nov-2020
$350
$90.21 (34.72%)
$325
2 months 27 days ago
(24-Oct-2025)
6/12 (50%)
$52.53 (17.66%)
183
Buy
Since 12-Dec-2024
$320
$60.21 (23.18%)
$390
5 months 26 days ago
(25-Jul-2025)
2/4 (50%)
$56.71 (21.54%)
19
Buy
Since 12-Dec-2024
$285
$25.21 (9.70%)
$390
11 months 6 days ago
(14-Feb-2025)
6/8 (75%)
$70.66 (32.97%)
61
Buy
Since 14-Feb-2025
$275
$15.21 (5.85%)
$250
11 months 6 days ago
(14-Feb-2025)
2/2 (100%)
$60.66 (28.30%)
97
What Year was the first public recommendation made by Juan Avendano?